Immix Biopharma Inc. (NASDAQ: IMMX) Stock Information | RedChip

Immix Biopharma Inc. (NASDAQ: IMMX) Listen to this Section


$1.90
+0.0050 ( +0.27% ) 78.2K

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Market Data


Open


$1.90

Previous close


$1.89

Volume


78.2K

Market cap


$52.16M

Day range


$1.83 - $1.92

52 week range


$1.55 - $7.75

Insider Ownership Transactions

Total Amount Purchased: -560,725.00 | $ -1,062,573.88

Date Type Amount Purchased Purchaser
2024-06-10 Buy 2500.00 Morris Gabriel S
2024-06-05 Buy 3300.00 Morris Gabriel S
2024-06-05 Buy 3300.00 Rachman Ilya M
2024-05-20 Sale -21587.00 Ng Carey
2024-05-20 Sale -87740.00 Adams Helen C.
2024-05-20 Sale -25002.00 Marquet Magda
2024-05-20 Sale -218359.00 Rachman Ilya M
2024-05-20 Sale -21587.00 Hsu Jason
2024-05-20 Sale -1332.00 BUCHAN JANE
2024-05-20 Sale -194218.00 Morris Gabriel S

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
8-k 8K-related 14 Jun 14, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 Jun 10, 2024
4 Insider transactions 1 Jun 05, 2024
4 Insider transactions 1 Jun 05, 2024
4 Insider transactions 1 May 20, 2024
4 Insider transactions 1 May 20, 2024
4 Insider transactions 1 May 20, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.